T. Rowe Price Associates’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Sell
76,784
-161,464
-68% -$2.76M ﹤0.01% 1843
2025
Q1
$15.2M Sell
238,248
-3,415
-1% -$218K ﹤0.01% 1021
2024
Q4
$29.4M Buy
241,663
+5,130
+2% +$624K ﹤0.01% 894
2024
Q3
$29.5M Sell
236,533
-103,497
-30% -$12.9M ﹤0.01% 896
2024
Q2
$53.7M Sell
340,030
-164,938
-33% -$26.1M 0.01% 705
2024
Q1
$65.4M Sell
504,968
-234,768
-32% -$30.4M 0.01% 650
2023
Q4
$71.3M Sell
739,736
-48,220
-6% -$4.65M 0.01% 605
2023
Q3
$95.5M Buy
787,956
+7,035
+0.9% +$853K 0.01% 519
2023
Q2
$89.4M Sell
780,921
-390,521
-33% -$44.7M 0.01% 548
2023
Q1
$161M Buy
1,171,442
+334,749
+40% +$46.1M 0.02% 417
2022
Q4
$108M Sell
836,693
-382,178
-31% -$49.5M 0.02% 476
2022
Q3
$135M Buy
1,218,871
+55,024
+5% +$6.08M 0.02% 434
2022
Q2
$87.2M Buy
1,163,847
+27,042
+2% +$2.03M 0.01% 704
2022
Q1
$88.8M Buy
1,136,805
+401,247
+55% +$31.3M 0.01% 766
2021
Q4
$66.2M Buy
735,558
+26,114
+4% +$2.35M 0.01% 901
2021
Q3
$65.6M Sell
709,444
-11,748
-2% -$1.09M 0.01% 915
2021
Q2
$56.1M Buy
721,192
+17,039
+2% +$1.32M 0.01% 986
2021
Q1
$52.5M Sell
704,153
-598,498
-46% -$44.6M 0.01% 983
2020
Q4
$222M Sell
1,302,651
-38,402
-3% -$6.55M 0.02% 499
2020
Q3
$188M Sell
1,341,053
-225,320
-14% -$31.6M 0.02% 497
2020
Q2
$251M Sell
1,566,373
-120,426
-7% -$19.3M 0.03% 429
2020
Q1
$165M Sell
1,686,799
-1,635,105
-49% -$160M 0.03% 457
2019
Q4
$429M Sell
3,321,904
-466,165
-12% -$60.2M 0.06% 328
2019
Q3
$285M Sell
3,788,069
-114,158
-3% -$8.6M 0.04% 377
2019
Q2
$593M Buy
3,902,227
+359,160
+10% +$54.6M 0.08% 251
2019
Q1
$422M Sell
3,543,067
-843,109
-19% -$100M 0.06% 295
2018
Q4
$479M Buy
4,386,176
+311,176
+8% +$34M 0.08% 239
2018
Q3
$658M Sell
4,075,000
-420,963
-9% -$68M 0.1% 218
2018
Q2
$594M Buy
4,495,963
+1,097,796
+32% +$145M 0.09% 220
2018
Q1
$252M Buy
3,398,167
+1,528,091
+82% +$113M 0.04% 404
2017
Q4
$104M Buy
1,870,076
+1,087,295
+139% +$60.5M 0.02% 625
2017
Q3
$35.5M Buy
782,781
+515,862
+193% +$23.4M 0.01% 980
2017
Q2
$9M Sell
266,919
-93,754
-26% -$3.16M ﹤0.01% 1336
2017
Q1
$10.7M Sell
360,673
-20,500
-5% -$607K ﹤0.01% 1320
2016
Q4
$10.5M Sell
381,173
-153,295
-29% -$4.21M ﹤0.01% 1304
2016
Q3
$32.8M Buy
534,468
+475,600
+808% +$29.2M 0.01% 948
2016
Q2
$1.12M Buy
58,868
+6,100
+12% +$116K ﹤0.01% 1671
2016
Q1
$1.03M Buy
52,768
+21,100
+67% +$412K ﹤0.01% 1695
2015
Q4
$1.22M Buy
31,668
+120
+0.4% +$4.63K ﹤0.01% 1637
2015
Q3
$1.01M Sell
31,548
-7,200
-19% -$231K ﹤0.01% 1700
2015
Q2
$1.18M Buy
38,748
+12,200
+46% +$371K ﹤0.01% 1699
2015
Q1
$353K Buy
26,548
+12,400
+88% +$165K ﹤0.01% 2118
2014
Q4
$205K Hold
14,148
﹤0.01% 2342
2014
Q3
$299K Hold
14,148
﹤0.01% 2150
2014
Q2
$421K Buy
14,148
+2,500
+21% +$74.4K ﹤0.01% 2019
2014
Q1
$280K Buy
+11,648
New +$280K ﹤0.01% 2189
2013
Q4
Sell
-17,048
Closed -$805K 2510
2013
Q3
$805K Sell
17,048
-857,200
-98% -$40.5M ﹤0.01% 1727
2013
Q2
$33.3M Buy
+874,248
New +$33.3M 0.01% 920